Publication | Open Access
Phase II Study of Concurrent Chemoradiotherapy at the Dose of 50.4 Gy with Elective Nodal Irradiation for Stage II-III Esophageal Carcinoma
90
Citations
25
References
2013
Year
Chemoradiation therapy at a dose of 50.4 Gy with elective nodal irradiation is promising with a manageable tolerability profile in esophageal cancer patients.
| Year | Citations | |
|---|---|---|
Page 1
Page 1